AKF

American Kidney Fund and Alonzo Mourning Call for More Awareness and Understanding of APOL1-Mediated Kidney Disease (AMKD) on Capitol Hill

Retrieved on: 
Tuesday, April 9, 2024
American Kidney Fund, African Americans, Health, Apolipoprotein L1, L1, APOL1, Genetic testing, Disease, Risk, Policy, Black, Kidney disease, Vertex Pharmaceuticals, AKF, Pharmaceutical industry

ROCKVILLE, Md., April 09, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) and basketball Hall-of-Famer Alonzo Mourning are teaming up on Capitol Hill for a roundtable and policy discussion to highlight the stories of people with APOL1-mediated kidney disease (AMKD) and spread awareness of this rapidly progressive form of genetic kidney disease.

Key Points: 
  • ROCKVILLE, Md., April 09, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) and basketball Hall-of-Famer Alonzo Mourning are teaming up on Capitol Hill for a roundtable and policy discussion to highlight the stories of people with APOL1-mediated kidney disease (AMKD) and spread awareness of this rapidly progressive form of genetic kidney disease.
  • The roundtable is being held in conjunction with the nation’s first ever AMKD Awareness Day , which AKF is launching on April 30, 2024.
  • “For many years, I have publicly shared my personal kidney disease story to help educate people about APOL1-mediated kidney disease,” said Mourning.
  • Also participating in the roundtable discussion are:
    Support for AMKD Awareness Day activities, including this roundtable discussion, is provided by Vertex Pharmaceuticals Incorporated.

American Kidney Fund Launches Phosphorus Management Education and Awareness Campaign

Retrieved on: 
Tuesday, March 19, 2024
Phosphorus, Hyperphosphatemia, American Kidney Fund, Disease, Education, Patient, Cramp, Kidney failure, Kidney disease, Diet, AKF, Skin, Dialysis, Blood

ROCKVILLE, Md., March 19, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced a new patient-focused educational awareness campaign on managing high phosphorus, also known as hyperphosphatemia.

Key Points: 
  • ROCKVILLE, Md., March 19, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced a new patient-focused educational awareness campaign on managing high phosphorus, also known as hyperphosphatemia.
  • AKF’s phosphorus management education campaign will work to raise awareness among dialysis patients about why phosphorus levels matter, ways to manage phosphorus intake with low phosphorus foods and fluids, and information about existing and new phosphate lowering medications, including phosphate blockers.
  • The campaign will provide people with a host of resources, including a patient-facing education page on AKF’s website; a page on AKF’s nutrition website, Kidney Kitchen ®; downloadable guides on talking to your doctor about phosphorus and low phosphorus foods; and a patient-facing session on hyperphosphatemia management at Kidney Action Week 2024 .
  • We hope that this campaign provides much-needed information to patients and families and can make an impact on their disease management.”

American Kidney Fund Convenes Nation’s Kidney Community for 2024 Kidney Action Week™ March 18-22

Retrieved on: 
Monday, March 18, 2024
American Kidney Fund, Patient, Nephrology, Kidney disease, AKF, Caregiver

ROCKVILLE, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) kicks off its fifth annual Kidney Action Week ™, the nation’s only free online conference that draws patients, caregivers, nephrologists, researchers and other experts to participate in a weeklong series of sessions related to kidney disease.

Key Points: 
  • ROCKVILLE, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) kicks off its fifth annual Kidney Action Week ™, the nation’s only free online conference that draws patients, caregivers, nephrologists, researchers and other experts to participate in a weeklong series of sessions related to kidney disease.
  • More than 5,000 people are expected to participate in 2024 Kidney Action Week.
  • The event is part of AKF’s Kidney Month observance, which is focused on equipping and empowering people with the tools they need to prioritize their kidney health and fight kidney disease.

American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Against Kidney Disease

Retrieved on: 
Friday, March 15, 2024
American Kidney Fund, Candid (organization), Disease, Caregiver, Vertex Pharmaceuticals, Risk, GSK, Boehringer Ingelheim, GSK plc, Kidney disease, AKF, Therapy, Kidney, Eli Lilly and Company, Platinum, Charity Navigator, Corporation, Pharmaceutical industry

ROCKVILLE, Md., March 15, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce its 2024 Class of Corporate Members who serve as strategic partners in AKF’s Corporate Membership Program .

Key Points: 
  • ROCKVILLE, Md., March 15, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce its 2024 Class of Corporate Members who serve as strategic partners in AKF’s Corporate Membership Program .
  • Corporate Members provide essential support to AKF as it continues its fight against kidney disease on all fronts—from prevention through post-transplant living.
  • “Our Corporate Members—both new and returning—help make the work AKF does for the kidney community possible,” said LaVarne A. Burton, AKF President and CEO.
  • Corporate Members fund AKF’s essential work, including:
    Award-winning, evidence-based kidney health education resources that reach millions of people living with kidney disease, caregivers, living organ donors and health care providers each year
    The Corporate Membership Program is open to institutional partners that support AKF’s mission of fighting kidney disease and helping people live healthier lives.

Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease

Retrieved on: 
Thursday, February 29, 2024
AstraZeneca, Caregiver, American Kidney Fund, Eli Lilly and Company, AKF, Dialysis, Pfizer, Notifiable disease, Nephrology, Boehringer Ingelheim, Patient, Genetic testing, Kidney disease, Senior counsel, Disease, Kidney, Diagnosis, Research, Kidney failure, Pharmaceutical industry

During Kidney Month, AKF calls on members of the kidney community and the general public to join in solidarity in support of everyone affected by kidney disease.

Key Points: 
  • During Kidney Month, AKF calls on members of the kidney community and the general public to join in solidarity in support of everyone affected by kidney disease.
  • One of the hallmarks of Kidney Month at AKF is Kidney Action Week , which will be held March 18-22.
  • This free, virtual event will bring together patients, nephrologists, renal dieticians, caregivers and other kidney experts for a weeklong series of sessions about a variety of topics related to kidney disease, including dialysis, kidney disease prevention, kidney-friendly eating, transplant, innovations in kidney disease and more.
  • In addition, people with kidney disease have a higher chance of developing other health problems, such as heart disease.

Where You Live Impacts Your Ability to Save a Life Through Living Organ Donation, According to the 2024 American Kidney Fund Report Card

Retrieved on: 
Thursday, February 22, 2024
Ambassador, Chronic kidney disease, Health insurance, American Kidney Fund, Latino, AKF, Dialysis, News, Report card, Transplant, Skin, Life, HIPP, CKD, Disability, House, FMLA, Telephone numbers in Hungary, Policy, Family, Legislation, Louisiana House of Representatives, Patient, Kidney disease, Insurance, Kidney, Representative, Child, Health equity, The Report Card, Mortality, Research, Senate, Kidney failure

Receiving a kidney from a living donor is the best option for someone in need of a new kidney.

Key Points: 
  • Receiving a kidney from a living donor is the best option for someone in need of a new kidney.
  • However, six states – Alabama, Montana, New Hampshire, Tennessee, South Dakota and Vermont – have zero policy protections (F grade) for living organ donors.
  • How All 50 States + DC Fared on the 2024 State of the States: American Kidney Fund Report Card
    Currently, chronic kidney disease (CKD) affects more than 1 in 7 adults in the U.S.
  • “Where you live should not impact whether you are able to save a life through kidney donation, but our 2024 Report Card suggests that this may be the case.

American Kidney Fund Announces April 30 as the First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day

Retrieved on: 
Thursday, January 25, 2024
Vertex Pharmaceuticals, Apolipoprotein L1, Dialysis, Central African, Focal segmental glomerulosclerosis, Kidney failure, Health, Foreign policy, Kidney, FSGS, APOL1, Gene, AKF, Risk, Kidney disease, Genetic testing, Mutation, Disease, Congress, L1, Education, American Kidney Fund, Pharmaceutical industry

ROCKVILLE, Md., Jan. 25, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce that April 30, 2024 will mark the nation’s first ever AMKD Awareness Day .

Key Points: 
  • ROCKVILLE, Md., Jan. 25, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce that April 30, 2024 will mark the nation’s first ever AMKD Awareness Day .
  • Building on AKF’s educational campaign for the condition, AMKD Awareness Day aims to spread awareness of APOL1-mediated kidney disease (AMKD) , a spectrum of kidney diseases associated with variants (mutations) in the apolipoprotein L1 (APOL1) gene and linked to an increased risk for rapidly progressing kidney disease in people of Western and Central African descent.
  • People with two mutations are at higher risk of developing genetic forms of kidney disease such as focal segmental glomerulosclerosis (FSGS).
  • Additionally, AKF will provide resources and ways to engage and raise awareness of the important connection between APOL1 gene variants and kidney disease in the months ahead.

American Kidney Fund Hosts Fourth National Summit on Unknown Causes of Kidney Disease

Retrieved on: 
Tuesday, December 5, 2023
Nephrology, Cardiology, Public policy, Genetic counseling, Food, Risk, Division, Research, Kidney disease, Vertex Pharmaceuticals, Health, Education, Legislation, Therapy, Columbia University, Focal segmental glomerulosclerosis, Kidney, COVID-19, Patient, Diagnosis, AKF, American Kidney Fund, Pharmaceutical industry

ROCKVILLE, Md., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) will convene more than 100 medical leaders, patient advocates and academic and industry leaders for the fourth national summit of its Unknown Causes of Kidney Disease (UCKD) Project, which seeks to improve understanding of how undiagnosed or misdiagnosed causes of kidney disease directly impact patient care and outcomes.

Key Points: 
  • ROCKVILLE, Md., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) will convene more than 100 medical leaders, patient advocates and academic and industry leaders for the fourth national summit of its Unknown Causes of Kidney Disease (UCKD) Project, which seeks to improve understanding of how undiagnosed or misdiagnosed causes of kidney disease directly impact patient care and outcomes.
  • This will be the first in-person summit after three years of virtual summits due to the pandemic.
  • This week’s summit, which will be held in Arlington, Virginia, will further explore how the kidney community can drive innovation in research, diagnosis and treatment of the underlying causes of kidney disease.
  • “Finding out the root cause of one’s kidney disease can bring crucial clinical insights to providers and have life-saving implications for individuals.

American Kidney Fund Renews Calls for Early Diagnosis and Treatment of Chronic Kidney Disease in New Report

Retrieved on: 
Thursday, November 30, 2023
Food, Nephrology, Treatment, Novartis, Caregiver, Chronic kidney disease, Diagnosis, FDA, Kidney disease, PAI, Disease, Caregiver burden, Therapy, Risk, Medicare, CSL Vifor, Patient, AKF, American Kidney Fund, Pharmaceutical industry

Advocates urge the U.S. Preventive Services Task Force to make recommendations on screening for chronic kidney disease, and strongly support legislative action for direct Medicare reimbursement to genetic counselors.

Key Points: 
  • Advocates urge the U.S. Preventive Services Task Force to make recommendations on screening for chronic kidney disease, and strongly support legislative action for direct Medicare reimbursement to genetic counselors.
  • Educating health care providers and patients about kidney disease and treatment options: Patient advocates have identified patient education and navigation as major challenges.
  • Many people at high risk aren’t aware of their risk factors and don’t know when to ask for screening for kidney disease.
  • The report also recommends identifying opportunities for advocates and policymakers to weigh in on policies that impact chronic kidney disease care.

NEVADA KING INTERCEPTS 4.96 G/T AU OVER 27.4M AND 2.33 G/T OVER 74.7M FURTHER DEFINING HIGH-GRADE MINERALIZATION ACROSS THE ATLANTA MINE FAULT ZONE AND THE WEST ATLANTA GRABEN ZONE

Retrieved on: 
Monday, October 30, 2023
Section, AKF, WAF, Printed circuit board, Road, Atlanta

*Denotes 45o angle hole with true

Key Points: 
  • *Denotes 45o angle hole with true
    mineralized thicknesses in angle hole estimated to be 65% to 70% of reported drill intercept length.
  • 4.96 g/t Au over 27.4m in AT23NS-70 is hosted within silicified breccia and adjacent porphyritic rhyolitic breccia dikes/sills.
  • Higher Au-Ag grades are frequently found in the silica breccia proximal to these tuff dikes further north and south along the Atlanta King Fault ("AKF").
  • If this drilling is successful, it will open up an entirely new frontier that has never been previously explored."